|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R82.89 |
Other abnormal findings on cytological and histological examination of urine
|
R8289 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 34.26%
|
32.56%
|
13.78%
|
7.08%
|
4.27%
|
2.27%
|
1.60%
|
0.99%
|
0.86%
|
0.61%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R82.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88112
|
CYTOPATH CELL ENHANCE TECH |
1,480
|
1,556
|
|
87086
|
URINE CULTURE/COLONY COUNT |
391
|
392
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
316
|
317
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
277
|
277
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
259
|
259
|
|
87088
|
URINE BACTERIA CULTURE |
209
|
211
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
196
|
215
|
|
52000
|
CYSTOURETHROSCOPY |
193
|
193
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
191
|
15,622
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
187
|
206
|
|
88108
|
CYTOPATH CONCENTRATE TECH |
186
|
199
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
181
|
389
|
|
81003
|
URINALYSIS AUTO W/O SCOPE |
158
|
158
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
144
|
3,339
|
|
J3010
|
FENTANYL CITRATE INJECTION |
135
|
191
|
|
74178
|
CT ABD&PLV WO CNTR FLWD CNTR |
124
|
124
|
|
J2405
|
ONDANSETRON HCL INJECTION |
121
|
484
|
|
80048
|
METABOLIC PANEL TOTAL CA |
118
|
118
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
116
|
116
|
|
82565
|
ASSAY OF CREATININE |
101
|
101
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R82.89 related to the following DRG Codes:
695-696
|
